Name: Generic Drug User Fee Amendments: Accelerating Patient Access to Generic Drugs (en Inglés)
Price: 29350.00 CLP
Availability: InStock
Author: Committee on Health, Education Labor a.
ISBN: 9781986830379

portada Generic Drug User Fee Amendments: Accelerating Patient Access to Generic Drugs (en Inglés)

Formato

Libro Físico

Autor

Education Labor a. Committee on Health

Editorial

Createspace Independent Publishing Platform

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

27.9 x 21.6 x 0.2 cm

Peso

0.13 kg.

ISBN13

9781986830379

Categorías

Sociedad y cultura general
Las políticas del gobierno central

Generic Drug User Fee Amendments: Accelerating Patient Access to Generic Drugs (en Inglés)

Education Labor a. Committee on Health (Autor) · Createspace Independent Publishing Platform · Tapa Blanda

Libro Nuevo

$ 29.350

$ 40.760

Ahorras: $ 11.410

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 16 de Julio y el Martes 23 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Generic Drug User Fee Amendments: Accelerating Patient Access to Generic Drugs (en Inglés)"

Since 2012, the FDA has received nearly $1 billion in user fees, those are the fees that are negotiated between the FDA and the generic drug makers to give the agency additional resources intended to speed the review of safe and effective generic drugs. [The Generic Drug User Fee] does not seem to be living up to Congress or the patient's expectations, as the number of generic drugs approved each year remains about the same. The user fee agreements are due to be reauthorized, and so now seems to be a good time to take a look at what has happened. The Generic Drug Program was started 30 years ago by Senator Hatch and Representative Henry Waxman. It has increased competition and lowered drug prices. The program was created to make it easier for generic drugs to come in. Generic drugs are those drugs that are allowed to come into the market after a drug manufacturer's patent expires. Generic drugs have to have FDA approval also, but they do not have to have full clinical trials, and so a lot of expense is avoided. As a result, more generic drugs on the market create competition and lower prices for consumers. Today, 88 percent of prescription drugs purchased in the United States are generic drugs. Thirty years ago, that number was zero.